The historical rank and industry rank for Paragon 28's EV-to-EBIT or its related term are showing as below:
FRA:7GQ'
s EV-to-EBIT Range Over the Past 10 Years
Min: -1206.6 Med: -26.3 Max: -10.96
Current: -14.95
During the past 5 years, the highest EV-to-EBIT of Paragon 28 was -10.96. The lowest was -1206.60. And the median was -26.30.
FRA:7GQ's EV-to-EBIT is ranked worse than 100% of 456
companies
in the Medical Devices & Instruments industry
Industry Median: 20.155
vs FRA:7GQ: -14.95
The historical data trend for Paragon 28's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Paragon 28's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paragon 28's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paragon 28's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Paragon 28's EV-to-EBIT falls into.
Paragon 28 EV-to-EBIT Calculation
Paragon 28's EV-to-EBIT for today is calculated as:
Paragon 28's current Enterprise Value is €648.3 Mil.
Paragon 28's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-43.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paragon 28 (FRA:7GQ) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Paragon 28's Enterprise Value for the quarter that ended in Mar. 2024 was €993.7 Mil.
Paragon 28's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-43.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paragon 28 EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Paragon 28's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, charcot, fracture fixation, hallux valgus, hammertoe, and flatfoot.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:7GQ has been successfully added to your 